Aurora Cannabis (ACB) Assets Average (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Assets Average of $497.1 million for Q1 2026, down 17.93% year-over-year from $605.8 million in Q1 2025, and down 10.1% quarter-over-quarter from $553.0 million in Q4 2025.
Aurora Cannabis (ACB) Assets Average (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Assets Average for 9 consecutive years, with $497.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets Average fell 17.93% year-over-year to $497.1 million; the TTM figure through Mar 2026 stood at $497.1 million (down 17.93% YoY), while the FY2026 annual figure was $525.8 million, down 14.9% from the prior year.
- Assets Average fell to $497.1 million in Q1 2026 per ACB's latest filing, from $553.0 million in the prior quarter.
- Across five years, Assets Average topped out at $1.6 billion in Q1 2022 and bottomed at $497.1 million in Q1 2026.
- Historically, Assets Average has averaged $718.3 million across 5 years, with a median of $611.3 million in 2024.
- Annual changes were most pronounced in 2022 — Assets Average plunged 58.78% — and 2024, when it declined 0.13%.
- Aurora Cannabis' Assets Average stood at $825.6 million in 2022, then retreated by 26.68% to $605.3 million in 2023, then slipped by 0.13% to $604.6 million in 2024, then fell by 8.54% to $553.0 million in 2025, then declined by 10.1% to $497.1 million in 2026.
- Business Quant data shows ACB's Assets Average at $497.1 million in Q1 2026, $553.0 million in Q4 2025, and $577.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 5.97 Bn |
| 10 | Aurora Cannabis | 232.22 Mn | 159.91 Mn | 25.75 Mn | 443.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 497.13 Mn |
| Dec 31, 2025 | 552.96 Mn |
| Sep 30, 2025 | 577.32 Mn |
| Jun 30, 2025 | 599.46 Mn |
| Mar 31, 2025 | 605.76 Mn |
| Dec 31, 2024 | 604.57 Mn |
| Sep 30, 2024 | 602.02 Mn |
| Jun 30, 2024 | 617.28 Mn |
| Mar 31, 2024 | 611.31 Mn |
| Dec 31, 2023 | 605.34 Mn |
| Sep 30, 2023 | 614.99 Mn |
| Jun 30, 2023 | 652.36 Mn |
| Mar 31, 2023 | 719.73 Mn |
| Dec 31, 2022 | 825.65 Mn |
| Sep 30, 2022 | 873.77 Mn |
| Jun 30, 2022 | 1.05 Bn |
| Mar 31, 2022 | 1.61 Bn |
| Dec 31, 2021 | 2.00 Bn |
| Sep 30, 2021 | 2.08 Bn |
| Jun 30, 2021 | 2.18 Bn |